相关实验视频

Updated: Jun 23, 2025

Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease

Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease

Published on: April 12, 2021

纤维化间歇性肺部疾病的基于细胞的疗法,目前的状况和iPSC衍生的细胞的潜在应用

Yusuke Nakamura^1,2, Seiji Niho¹, Yasuo Shimizu^1,2,3

¹Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, Mibu 321-0293, Japan.

|June 19, 2024

概括

诱导多能干细胞 (iPSCs) 显示出治疗纤维化间歇性肺病 (FILDs) 的前景. 从iPSC衍生的细胞提供一致的质量和稳定的供应,克服了FILD目前中细胞干细胞 (MSC) 疗法的局限性.

科学领域:

再生医学是一种再生医学.
肺部病理学肺部病理学
干细胞生物学干细胞生物学

背景情况:

纤维化间歇性肺部疾病 (FILDs),包括异常性肺纤维化 (IPF),是渐进的,预后不佳.
目前的FILD管理依赖于抗纤维性药物来减缓进展,需要新的治疗策略.
基于细胞的疗法,特别是介质干细胞 (MSCs),正在研究用于FILD治疗.

研究的目的:

审查诱导多能干细胞 (iPSCs) 治疗FILDs的潜力.
为了比较基于iPSC的治疗与现有的基于MSC的FILD治疗方法.
在FILD治疗中讨论iPSC衍生细胞的优势和未来前景.

主要方法:

对iPSCs,FILDs和基于细胞的治疗方法的现有文献的审查.
在FILD模型中分析MSC和iPSC的机制和副作用.
讨论iPSC衍生细胞在解决MSC治疗中的挑战方面的潜力.

主要成果:

MSC在FILD中表现出抗纤维菌作用,但面临着捐助者变异性和供应方面的挑战.
iPSCs也表现出抗纤维素的特性,尽管研究程度不如MSCs那么广泛.
从iPSC衍生细胞提供了持续质量和稳定供应的潜力,解决了MSC的局限性.

结论:

来自iPSC的细胞疗法为FILD治疗提供了一个有前途的途径.
持续的质量和稳定的iPSC衍生细胞供应可以克服当前的治疗障碍.
对iPSC机制和临床应用的进一步研究对于FILD管理是有必要的.

关键词:

膜2型上皮细胞 (AT2s)纤维化间歇性肺病 (FILDs) 是一种肺部疾病.纤维性过敏性肺炎 (fHP) 是一种异形性肺纤维化 (IPF) 是一种疾病.诱导多能干细胞 (iPSCs) 是一种肺的原始细胞是肺的原始细胞.中介细胞干细胞 (MSCs)干细胞是干细胞的组成部分.

更多相关视频

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

Published on: April 30, 2019

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients

Published on: October 16, 2016

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...

Introduction to Fibroblasts

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...